Tag Archives: uthr

United Therapeutics Blood Pressure Drug Spurs Q4 Beat

United Therapeutics (UTHR) early Tuesday topped fourth-quarter sales and profit views, as the maker of therapies to treat cardiovascular disease, infectious diseases and cancer benefited from a strong performance from its new Orenitram drug to treat high blood pressure. United Therapeutics logged fourth-quarter earnings of $2.17 a share. That reversed a 60-cent per-share loss in the year-earlier quarter and Wall Street consensus estimates by 7

United Therapeutics Blood Pressure Drug Lifts Q4

United Therapeutics (UTHR) early Tuesday topped fourth-quarter sales and profit views, as the maker of therapies to treat cardiovascular disease, infectious diseases and cancer benefited from a strong performance from its new Orenitram drug to treat high blood pressure. United Therapeutics logged fourth-quarter earnings of $2.17 a share. That reversed a 60-cent per-share loss in the year-earlier quarter and Wall Street consensus estimates by 7

A Look At 5 IBD 50 Stocks With Upcoming Earnings

Five notable IBD 50 stocks are all set to issue their quarterly earnings in the coming week. United Therapeutics (UTHR) reports before the open on Tuesday. The cancer therapy developer’s stock is up 20% so far this year. Valeant Pharmaceuticals (VRX) also reports before the open on Tuesday. It could close its $160-a-share buyout deal with industry group peer Salix Pharmaceuticals (SLXP) soon. Valeant shares are up 21% in 2015. Apple (AAPL) chip